Immunohistochemical Analysis with Multiple Antibodies in Search of Prognostic Markers for Clear Cell Renal Cell Carcinoma

Urology

Volumn 69, Issue 5, 2007, Pages 843-848

  Phuoc, Nguyen Ba ^a   Ehara, Hidetoshi ^a   Gotoh, Takahiro ^a   Nakano, Masahiro ^a   Yokoi, Shigeaki ^a   Deguchi, Takashi ^a   Hirose, Yoshinobu ^b  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b GIFU UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CAVEOLIN 1; CISPLATIN; CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53; TEGAFUR; TUMOR MARKER; URACIL; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIBODIES, NEOPLASM; BIOPSY, NEEDLE; CARCINOMA, RENAL CELL; CYCLIN D1; FEMALE; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEPHRECTOMY; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENE PROTEINS C-BCL-2; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 34247637684     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.01.069     Document Type: Article

References (19)

1. Novick A.C., and Campbell S.C. Renal tumors. In: Walsh P.C., Retik A.B., Vaughan E.D., et al. (Eds). Campbell's Urology. 8th ed. vol 4 (2002), WB Saunders, Philadelphia 2672-2679
2. Lam J.S., Leppert J.T., Figlin R.A., et al. Surveillance following radical or partial nephrectomy for renal cell carcinoma. Curr Urol Rep 6 (2005) 7-18
3. Bui M.H., Visapaa H., Seligson D., et al. Prognostic value of carbonic anhydrase IX and Ki67 as predictors of survival for renal clear cell carcinoma. J Urol 171 (2004) 2461-2466
4. Kibel A.S., and Nelson J.B. Molecular genetics and cancer biology. In: Walsh P.C., Retik A.B., Vaughan E.D., et al. (Eds). Campbell's Urology. 8th ed. vol 4 (2002), WB Saunders, Philadelphia 2625-2660
5. Yildiz E., Gokce G., Kilicarslan H., et al. Prognostic value of the expression of Ki-67, CD44 and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinoma. BJU Int 93 (2004) 1087-1093
6. Horiguchi A., Asano T., Asakuma J., et al. Impact of caveolin-1 expression on clinicopathological parameters in renal cell carcinoma. J Urol 172 (2004) 718-722
7. Slamon D.J., Godophin W., Jones L.A., et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244 (1989) 707-712
8. Fuhrman S.A., Lasky L.C., and Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6 (1982) 655-663
9. Olumi A.F., Weidner N., and Presti J.C. p53 immunoreactivity correlates with Ki-67 and bcl-2 expression in renal cell carcinoma. Urol Oncol 6 (2001) 63-67
10. Ghanem M.A., Van Der Kwast T.H., Den Hollander J.C., et al. Expression and prognostic value of epidermal growth factor receptor, transforming growth factor-alpha, and c-erbB-2 in nephroblastoma. Cancer 92 (2001) 3120-3129
11. Aaltomaa S., Lipponen P., Ala-Opas M., et al. Prognostic value of Ki-67 expression in renal cell carcinomas. Eur Urol 31 (1997) 350-355
12. Hedberg Y., Davoodi E., Roos G., et al. Cyclin-D1 expression in human renal-cell carcinoma. Int J Cancer 84 (1999) 268-272
13. Zigeuner R., Ratschek M., Rehak P., et al. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue. Urology 63 (2004) 651-655
14. Campbell L., Gumbleton M., and Griffiths D.F. Caveolin-1 overexpression predicts poor disease-free survival of patients with clinically confined renal cell carcinoma. Br J Cancer 89 (2003) 1909-1913
15. Itoi T., Yamana K., Bilim V., et al. Impact of frequent Bcl-2 expression on better prognosis in renal cell carcinoma patients. Br J Cancer 90 (2004) 200-205
16. Korsmeyer S.J. Bcl-2: a repressor of lymphocyte death. Immunol Today 13 (1992) 285-288
17. Rioux-Leclercq N., Turlin B., Bansard J., et al. Value of immunohistochemical Ki-67 and p53 determinations as predictive factors of outcome in renal cell carcinoma. Urology 55 (2000) 501-505
18. Kim H.L., Seligson D., Liu X., et al. Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma. J Urol 173 (2005) 1496-1501
19. Lipponen P., Eskelinen M., Hietala K., et al. Expression of proliferating cell nuclear antigen (PC10) p53 protein and c-erbB-2 in renal adenocarcinoma. Int J Cancer 57 (1994) 275-280